Monday, November 2, 2026
25.4 C
Bengaluru

Indian Hospitals and Private Equity: Healthy for Patients?

If healthcare is so lucrative that global private equity firms are willing to write cheques of Rs 13,000–14,000 crore for a single mid-sized Indian hospital chain, why is the Indian government still reluctant to invest at scale?

Public health expenditure in India remains stubbornly low — around 1.4–1.8 per cent of GDP in recent National Health Accounts estimates, far short of the National Health Policy 2017 target of 2.5 per cent by 2025. The Centre’s own allocation hovers near 0.26–0.28 per cent of GDP.

States carry the bulk of the burden, yet the combined public effort has never matched the rhetoric of “health as a right.” Fiscal constraints, competing demands (defence, infrastructure, subsidies), and the political economy of short-term welfare schemes over long-term capacity building explain part of the story. The deeper issue is that governments prefer to underwrite demand (through insurance schemes like Ayushman Bharat) rather than own and operate supply at the scale private capital is now willing to fund.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

Anuj Pasrija has been elevated to Country Lead, Johnson...

Topics

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...
spot_img

Related Articles

spot_imgspot_img